Browse by author
Lookup NU author(s): Professor Brian Walker
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2014 The Authors. Published by Elsevier B.V.Benign prostatic hyperplasia and prostate cancer can be treated with the 5α-reductase inhibitors, finasteride and dutasteride, when pharmacodynamic biomarkers are useful in assessing response. A novel method was developed to measure the substrates and products of 5α-reductases (testosterone, 5α-dihydrotestosterone (DHT), androstenedione) and finasteride and dutasteride simultaneously by liquid chromatography tandem mass spectrometry, using an ABSciex QTRAP® 5500, with a Waters Acquity™ UPLC. Analytes were extracted from serum (500 μL) via solid-phase extraction (Oasis® HLB), with 13C3-labelled androgens and d9-finasteride included as internal standards. Analytes were separated on a Kinetex C18 column (150 x 3 mm, 2.6 μm), using a gradient run of 19 min. Temporal resolution of analytes from naturally occurring isomers and mass +2 isotopomers was ensured. Protonated molecular ions were detected in atmospheric pressure chemical ionisation mode and source conditions optimised for DHT, the least abundant analyte. Multiple reaction monitoring was performed as follows: testosterone (m/z 289→97), DHT (m/z 291→255), androstenedione (m/z 287→97), dutasteride (m/z 529→461), finasteride (m/z 373→317). Validation parameters (intra- and inter-assay precision and accuracy, linearity, limits of quantitation) were within acceptable ranges and biological extracts were stable for 28 days. Finally the method was employed in men treated with finasteride or dutasteride; levels of DHT were lowered by both drugs and furthermore the substrate concentrations increased.
Author(s): Upreti R, Naredo G, Faqehi AMM, Hughes KA, Stewart LH, Walker BR, Homer NZM, Andrew R
Publication type: Article
Publication status: Published
Print publication date: 01/01/2015
Online publication date: 14/08/2014
Acceptance date: 30/07/2014
ISSN (print): 0039-9140
ISSN (electronic): 1873-3573
PubMed id: 25281165
Altmetrics provided by Altmetric